Tuesday, February 10, 2015

FDA Approves First-Of-Kind Device to Treat Obesity

News Brief by Kanika Kamal 

Obesity has been an ongoing problem in modern America, growing as the years proceed. In fact, more than one-third of all adults in the United States are obese, leading to higher risk of heart attack, diabetes, stroke, and even cancer. Unfortunately, despite various weight loss programs and changes in lifestyle, many people have not been able to lose weight. Fortunately, the Food and Drug Administration as recently approved a new and unique weight loss treatment: the Maestro Rechargeable System.

      Through the Maestro Rechargeable System, patients have electrodes surgically implanted into their abdomen. The system works by sending electrical impulses to the vagus nerve in the abdomen, which is involved in signaling the brain to indicate hunger. The system is even equipped with adjustable settings so that physicians can provide the best, most personalized treatment to each person. To ensure the safety of this treatment, the manufacturers are conducting a five-year post-approval study where they will monitor 100 patients and collect the effectiveness and safety data. While there are side effects, such as nausea, pain, vomiting, and surgical complications, this revolutionary new treatment could help us combat obesity in a more effective way than ever before.

U.S. Food and Drug Administration. "FDA approves first-of-kind device to treat obesity." ScienceDaily. ScienceDaily, 29 January 2015. .
blog comments powered by Disqus

TuftScope: The Interdisciplinary Journal of Health, Ethics, and Policy

TuftScope is a student journal published biannually in conjunction with Tufts University since 2001. Funding is provided by the Tufts Community Union Senate. The opinions expressed on this weblog are solely those of the authors. The staff reserves the right to edit blog postings for clarity and to remove nonfunctional links.

  © Free Blogger Templates Autumn Leaves by Ourblogtemplates.com 2008

Back to TOP